Beyond metabolic alterations, abnormal epigenetic modifications, NF-κB activation, decreased nuclear factor erythroid 2- related factor 2 (Nrf2) activity, and hyperglycemia-induced mitochondrial dysfunction contribute to ROS overproduction in DR [55]. Here, NFE2L2 is linked to Hyperglycemia.